Support Line: 0800 002 9002
General Enquiries: 01223 870008
  »  Kidney Cancer News  »  TKI Treatment Breaks May Not Impact Outcomes in RCC

TKI Treatment Breaks May Not Impact Outcomes in RCC

by | Mar 8, 2023 | Kidney Cancer News | 0 comments

Patients with advanced clear cell renal cell carcinoma are “unlikely” to experience a clinically meaningful decrease in overall survival following planned treatment cessation with a tyrosine kinase inhibitor.

Although non-inferiority could not be determined following planned treatment cessation vs conventional continuation with a first-line tyrosine kinase inhibitor, patients with advanced clear cell renal cell carcinoma did not experience a clinically meaningful decrease in survival outcomes, according to data from the phase 2/3 STAR trial.

Read the full story on Cancernetwork.com

<a href="https://www.kcuk.org.uk/author/mp/" target="_self">Malcolm Packer</a>

Malcolm Packer

Malcolm is Chief Executive Officer at Kidney Cancer UK and Kidney Cancer Scotland and has worked with the charity in various capacities for over 15 years.